Stem Cells Market Size, Share & Trends Report

Stem Cells Market Size, Share & Trends Analysis Report By Product (Adult Stem Cells, Human Embryonic Stem Cells), By Application (Regenerative Medicine), By Technology, Therapy, End-use, By Region, And Segment Forecasts, 2025 - 2030

Report ID: 978-1-68038-130-6
Number of Report Pages: 150
Format: PDF, Horizon Databook

Historical Range: 2018 - 2024
Forecast Period: 2025 - 2030
Industry: Healthcare

Market Segmentation

Stem Cells Product Outlook (Revenue, USD Million, 2018 - 2030)
- Adult Stem Cells (ASCs)
  - Hematopoietic
  - Mesenchymal
  - Neural
  - Epithelial/Skin
  - Others
- Human Embryonic Stem Cells (HESCs)
- Induced Pluripotent Stem Cells (iPSCs)
- Very Small Embryonic Like Stem Cells
Stem Cells Application Outlook (Revenue, USD Million, 2018 - 2030)
- Regenerative Medicine
  - Neurology
  - Orthopedics
  - Oncology
  - Hematology
  - Cardiovascular and Myocardial Infraction
  - Injuries
  - Diabetes
  - Liver Disorder
  - Incontinence
  - Others
- Drug Discovery and Development
Stem Cells Technology Outlook (Revenue, USD Million, 2018 - 2030)
- Cell Acquisition
  - Bone Marrow Harvest
  - Umbilical Blood Cord
  - Apheresis
- Cell Production
  - Therapeutic Cloning
  - In-vitro Fertilization
  - Cell Culture
  - Isolation
- Cryopreservation
- Expansion and Sub-Culture
Stem Cells Therapy Outlook (Revenue, USD Million, 2018 - 2030)
- Autologous
- Allogeneic
Stem Cells End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Pharmaceutical and Biotechnology Companies
- Hospitals & Cell Banks
- Academic & Research Institutes
Stem Cells Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Stem Cells Market, by Product 2018 - 2030 (USD Million)
    - Adult Stem Cells (ASCs)
      - Hematopoietic
      - Mesenchymal
      - Neural
      - Epithelial/Skin
      - Others
    - Human Embryonic Stem Cells (HESCs)
    - Induced Pluripotent Stem Cells (iPSCs)
    - Very Small Embryonic Like Stem Cells
  - North America Stem Cells Market, by Application 2018 - 2030 (USD Million)
    - Regenerative Medicine
      - Neurology
      - Orthopedics
      - Oncology
      - Hematology
      - Cardiovascular and Myocardial Infraction
      - Injuries
      - Diabetes
      - Liver Disorder
      - Incontinence
      - Others
    - Drug Discovery and Development
  - North America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
    - Cell Acquisition
      - Bone Marrow Harvest
      - Umbilical Blood CordApheresis
    - Cell Production
      - Therapeutic Cloning
      - In-vitro Fertilization
      - Cell Culture
      - Isolation
    - Cryopreservation
    - Expansion and Sub-Culture
  - North America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
    - Autologous
    - Allogeneic
  - North America Stem Cells Market, by End-use 2018 - 2030 (USD Million)
    - Pharmaceutical and Biotechnology Companies
    - Hospitals & Cell Banks
    - Academic & Research Institutes
  - U.S.
    - U.S. Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - U.S. Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - U.S. Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - U.S. Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - U.S. Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Canada
    - Canada Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Canada Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Canada Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Canada Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Canada Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Mexico
    - Mexico Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Mexico Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Mexico Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Mexico Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Mexico Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
- Europe
  - Europe Stem Cells Market, by Product 2018 - 2030 (USD Million)
    - Adult Stem Cells (ASCs)
      - Hematopoietic
      - Mesenchymal
      - Neural
      - Epithelial/Skin
      - Others
    - Human Embryonic Stem Cells (HESCs)
    - Induced Pluripotent Stem Cells (iPSCs)
    - Very Small Embryonic Like Stem Cells
  - Europe Stem Cells Market, by Application 2018 - 2030 (USD Million)
    - Regenerative Medicine
      - Neurology
      - Orthopedics
      - Oncology
      - Hematology
      - Cardiovascular and Myocardial Infraction
      - Injuries
      - Diabetes
      - Liver Disorder
      - Incontinence
      - Others
    - Drug Discovery and Development
  - Europe Stem Cells Market, by Technology 2018 - 2030 (USD Million)
    - Cell Acquisition
      - Bone Marrow Harvest
      - Umbilical Blood CordApheresis
    - Cell Production
      - Therapeutic Cloning
      - In-vitro Fertilization
      - Cell Culture
      - Isolation
    - Cryopreservation
    - Expansion and Sub-Culture
  - Europe Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
    - Autologous
    - Allogeneic
  - Europe Stem Cells Market, by End-use 2018 - 2030 (USD Million)
    - Pharmaceutical and Biotechnology Companies
    - Hospitals & Cell Banks
    - Academic & Research Institutes
  - UK
    - UK Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - UK Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - UK Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - UK Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - UK Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Germany
    - Germany Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Germany Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Germany Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Germany Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Germany Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - France
    - France Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - France Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - France Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - France Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - France Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Italy
    - Italy Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Italy Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Italy Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Italy Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Italy Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Spain
    - Spain Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Spain Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Spain Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Spain Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Spain Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Denmark
    - Denmark Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Denmark Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Denmark Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Denmark Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Denmark Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Sweden
    - Sweden Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Sweden Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Sweden Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Sweden Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Sweden Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Norway
    - Norway Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Norway Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Norway Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Norway Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Norway Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
- Asia Pacific
  - Asia Pacific Stem Cells Market, by Product 2018 - 2030 (USD Million)
    - Adult Stem Cells (ASCs)
      - Hematopoietic
      - Mesenchymal
      - Neural
      - Epithelial/Skin
      - Others
    - Human Embryonic Stem Cells (HESCs)
    - Induced Pluripotent Stem Cells (iPSCs)
    - Very Small Embryonic Like Stem Cells
  - Asia Pacific Stem Cells Market, by Application 2018 - 2030 (USD Million)
    - Regenerative Medicine
      - Neurology
      - Orthopedics
      - Oncology
      - Hematology
      - Cardiovascular and Myocardial Infraction
      - Injuries
      - Diabetes
      - Liver Disorder
      - Incontinence
      - Others
    - Drug Discovery and Development
  - Asia Pacific Stem Cells Market, by Technology 2018 - 2030 (USD Million)
    - Cell Acquisition
      - Bone Marrow Harvest
      - Umbilical Blood CordApheresis
    - Cell Production
      - Therapeutic Cloning
      - In-vitro Fertilization
      - Cell Culture
      - Isolation
    - Cryopreservation
    - Expansion and Sub-Culture
  - Asia Pacific Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
    - Autologous
    - Allogeneic
  - Asia Pacific Stem Cells Market, by End-use 2018 - 2030 (USD Million)
    - Pharmaceutical and Biotechnology Companies
    - Hospitals & Cell Banks
    - Academic & Research Institutes
  - China
    - China Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - China Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - China Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - China Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - China Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Japan
    - Japan Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Japan Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Japan Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Japan Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Japan Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - India
    - India Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - India Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - India Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - India Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - India Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - South Korea
    - South Korea Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - South Korea Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - South Korea Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - South Korea Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - South Korea Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Australia
    - Australia Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Australia Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Australia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Australia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Australia Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Thailand
    - Thailand Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Thailand Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Thailand Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - ThailandStem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Thailand Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
- Latin America
  - Latin America Stem Cells Market, by Product 2018 - 2030 (USD Million)
    - Adult Stem Cells (ASCs)
      - Hematopoietic
      - Mesenchymal
      - Neural
      - Epithelial/Skin
      - Others
    - Human Embryonic Stem Cells (HESCs)
    - Induced Pluripotent Stem Cells (iPSCs)
    - Very Small Embryonic Like Stem Cells
  - Latin America Stem Cells Market, by Application 2018 - 2030 (USD Million)
    - Regenerative Medicine
      - Neurology
      - Orthopedics
      - Oncology
      - Hematology
      - Cardiovascular and Myocardial Infraction
      - Injuries
      - Diabetes
      - Liver Disorder
      - Incontinence
      - Others
    - Drug Discovery and Development
  - Latin America Stem Cells Market, by Technology 2018 - 2030 (USD Million)
    - Cell Acquisition
      - Bone Marrow Harvest
      - Umbilical Blood CordApheresis
    - Cell Production
      - Therapeutic Cloning
      - In-vitro Fertilization
      - Cell Culture
      - Isolation
    - Cryopreservation
    - Expansion and Sub-Culture
  - Latin America Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
    - Autologous
    - Allogeneic
  - Latin America Stem Cells Market, by End-use 2018 - 2030 (USD Million)
    - Pharmaceutical and Biotechnology Companies
    - Hospitals & Cell Banks
    - Academic & Research Institutes
  - Brazil
    - Brazil Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Brazil Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Brazil Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Brazil Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Brazil Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Argentina
    - Argentina Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Argentina Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Argentina Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Argentina Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Argentina Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
- Middle East and Africa
  - Middle East and Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
    - Adult Stem Cells (ASCs)
      - Hematopoietic
      - Mesenchymal
      - Neural
      - Epithelial/Skin
      - Others
    - Human Embryonic Stem Cells (HESCs)
    - Induced Pluripotent Stem Cells (iPSCs)
    - Very Small Embryonic Like Stem Cells
  - Middle East and Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
    - Regenerative Medicine
      - Neurology
      - Orthopedics
      - Oncology
      - Hematology
      - Cardiovascular and Myocardial Infraction
      - Injuries
      - Diabetes
      - Liver Disorder
      - Incontinence
      - Others
    - Drug Discovery and Development
  - Middle East and Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
    - Cell Acquisition
      - Bone Marrow Harvest
      - Umbilical Blood CordApheresis
    - Cell Production
      - Therapeutic Cloning
      - In-vitro Fertilization
      - Cell Culture
      - Isolation
    - Cryopreservation
    - Expansion and Sub-Culture
  - Middle East and Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
    - Autologous
    - Allogeneic
  - Middle East and Africa Stem Cells Market, by End-use 2018 - 2030 (USD Million)
    - Pharmaceutical and Biotechnology Companies
    - Hospitals & Cell Banks
    - Academic & Research Institutes
  - South Africa
    - South Africa Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - South Africa Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - South Africa Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - South Africa Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - South Africa Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Saudi Arabia
    - Saudi Arabia Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Saudi Arabia Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Saudi Arabia Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Saudi Arabia Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Saudi Arabia Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - UAE
    - UAE Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - UAE Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - UAE Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - UAE Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - UAE Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes
  - Kuwait
    - Kuwait Stem Cells Market, by Product 2018 - 2030 (USD Million)
      - Adult Stem Cells (ASCs)
        
        Hematopoietic
        
        Mesenchymal
        
        Neural
        
        Epithelial/Skin
        
        Others
      - Human Embryonic Stem Cells (HESCs)
      - Induced Pluripotent Stem Cells (iPSCs)
      - Very Small Embryonic Like Stem Cells
    - Kuwait Stem Cells Market, by Application 2018 - 2030 (USD Million)
      - Regenerative Medicine
        
        Neurology
        
        Orthopedics
        
        Oncology
        
        Hematology
        
        Cardiovascular and Myocardial Infraction
        
        Injuries
        
        Diabetes
        
        Liver Disorder
        
        Incontinence
        
        Others
      - Drug Discovery and Development
    - Kuwait Stem Cells Market, by Technology 2018 - 2030 (USD Million)
      - Cell Acquisition
        
        Bone Marrow Harvest
        
        Umbilical Blood CordApheresis
      - Cell Production
        
        Therapeutic Cloning
        
        In-vitro Fertilization
        
        Cell Culture
        
        Isolation
      - Cryopreservation
      - Expansion and Sub-Culture
    - Kuwait Stem Cells Market, by Therapy 2018 - 2030 (USD Million)
      - Autologous
      - Allogeneic
    - Kuwait Stem Cells Market, by End-use 2018 - 2030 (USD Million)
      - Pharmaceutical and Biotechnology Companies
      - Hospitals & Cell Banks
      - Academic & Research Institutes

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Quantitative Analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.